225 related articles for article (PubMed ID: 17475907)
1. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
Schrezenmeier H; Passweg JR; Marsh JC; Bacigalupo A; Bredeson CN; Bullorsky E; Camitta BM; Champlin RE; Gale RP; Fuhrer M; Klein JP; Locasciulli A; Oneto R; Schattenberg AV; Socie G; Eapen M
Blood; 2007 Aug; 110(4):1397-400. PubMed ID: 17475907
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
Chu R; Brazauskas R; Kan F; Bashey A; Bredeson C; Camitta B; Chiang KY; Frangoul H; Gale RP; Gee A; George B; Goldman FD; Gross TG; Gupta V; Hale GA; Isola L; Ispizua AU; Lazarus H; Marsh J; Russell J; Sabloff M; Waller EK; Eapen M
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1018-24. PubMed ID: 21034842
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
4. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.
Eapen M; Le Rademacher J; Antin JH; Champlin RE; Carreras J; Fay J; Passweg JR; Tolar J; Horowitz MM; Marsh JC; Deeg HJ
Blood; 2011 Sep; 118(9):2618-21. PubMed ID: 21677312
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
[TBL] [Abstract][Full Text] [Related]
6. Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.
Sanz J; Moscardó F; Montoro J; Cano I; Guerreiro M; Dasí MA; Solves P; Lorenzo I; Gómez-Segui I; Montesinos P; Mora E; Arnao M; Sempere A; Jarque I; Carretero C; Senent L; Vicente A; Andreu R; Luna I; Balaguer-Roselló A; Carpio N; Sanz GF; Sanz MA; Piñana JL
Biol Blood Marrow Transplant; 2020 Jan; 26(1):83-87. PubMed ID: 31493538
[TBL] [Abstract][Full Text] [Related]
7. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
[TBL] [Abstract][Full Text] [Related]
8. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
9. HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.
Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Min WS; Park CW; Kim CC; Lee JW
Bone Marrow Transplant; 2010 Oct; 45(10):1497-501. PubMed ID: 20062099
[TBL] [Abstract][Full Text] [Related]
10. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
[TBL] [Abstract][Full Text] [Related]
11. Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors.
George B; Pn N; Devasia AJ; Kulkarni U; Korula A; Lakshmi KM; Abraham A; Srivastava A; Mathews V
Biol Blood Marrow Transplant; 2018 Mar; 24(3):494-500. PubMed ID: 29100905
[TBL] [Abstract][Full Text] [Related]
12. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
Kumar R; Kimura F; Ahn KW; Hu ZH; Kuwatsuka Y; Klein JP; Pasquini M; Miyamura K; Kato K; Yoshimi A; Inamoto Y; Ichinohe T; Wood WA; Wirk B; Seftel M; Rowlings P; Marks DI; Schultz KR; Gupta V; Dedeken L; George B; Cahn JY; Szer J; Lee JW; Ho AY; Fasth A; Hahn T; Khera N; Dalal J; Bonfim C; Aljurf M; Atsuta Y; Saber W
Biol Blood Marrow Transplant; 2016 May; 22(5):932-40. PubMed ID: 26797402
[TBL] [Abstract][Full Text] [Related]
13. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic transplantation using CD34
Purev E; Tian X; Aue G; Pantin J; Vo P; Shalabi R; Reger RN; Cook L; Ramos C; Cho E; Worthy T; Khuu H; Stroncek D; Young NS; Childs RW
Br J Haematol; 2017 Mar; 176(6):950-960. PubMed ID: 28169418
[TBL] [Abstract][Full Text] [Related]
15. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.
Bacigalupo A; Socié G; Hamladji RM; Aljurf M; Maschan A; Kyrcz-Krzemien S; Cybicka A; Sengelov H; Unal A; Beelen D; Locasciulli A; Dufour C; Passweg JR; Oneto R; Signori A; Marsh JC;
Haematologica; 2015 May; 100(5):696-702. PubMed ID: 25616576
[TBL] [Abstract][Full Text] [Related]
16. Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.
Perez-Albuerne ED; Eapen M; Klein J; Gross TJ; Lipton JM; Baker KS; Woolfrey A; Kamani N
Br J Haematol; 2008 Apr; 141(2):216-23. PubMed ID: 18307564
[TBL] [Abstract][Full Text] [Related]
17. Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia.
Chen X; Wei J; Huang Y; He Y; Yang D; Zhang R; Jiang E; Ma Q; Zhai W; Yao J; Zhang G; Feng S; Han M
Biol Blood Marrow Transplant; 2018 Jan; 24(1):86-90. PubMed ID: 29032265
[TBL] [Abstract][Full Text] [Related]
18. Unrelated donor transplantation: peripheral blood or bone marrow--does it matter?
Eapen M
Best Pract Res Clin Haematol; 2014; 27(3-4):278-82. PubMed ID: 25455278
[TBL] [Abstract][Full Text] [Related]
19. T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia.
Chorão P; Montoro J; Balaguer-Roselló A; Guerreiro M; Villalba M; Facal A; Solves P; Gómez-Segui I; Pasquini MC; Granados P; Bataller A; Louro A; de la Rubia J; Sanz MA; Sanz J
Transplant Cell Ther; 2023 May; 29(5):322.e1-322.e5. PubMed ID: 36682469
[TBL] [Abstract][Full Text] [Related]
20. HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.
Battiwalla M; Wang T; Carreras J; Deeg HJ; Ayas M; Bajwa RP; George B; Gupta V; Pasquini R; Schrezenmeier H; Passweg JR; Schultz KR; Eapen M
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1401-6. PubMed ID: 22387349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
